| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.73T | 7.24T | 6.76T | 6.57T | 6.22T | 5.63T |
| Gross Profit | 3.99T | 3.75T | 3.54T | 3.33T | 3.27T | 2.87T |
| EBITDA | 4.56T | 1.60T | 1.47T | 1.53T | 1.57T | 6.21T |
| Net Income | 3.73T | 1.15T | -227.65B | -970.14B | -1.71T | 4.99T |
Balance Sheet | ||||||
| Total Assets | 55.60T | 45.01T | 46.72T | 43.94T | 47.54T | 45.75T |
| Cash, Cash Equivalents and Short-Term Investments | 6.66T | 3.71T | 6.44T | 7.30T | 6.09T | 7.80T |
| Total Debt | 25.23T | 18.91T | 16.19T | 20.32T | 22.32T | 19.55T |
| Total Liabilities | 37.46T | 31.06T | 33.49T | 33.29T | 35.84T | 33.79T |
| Stockholders Equity | 15.46T | 11.56T | 11.16T | 9.03T | 9.98T | 10.21T |
Cash Flow | ||||||
| Free Cash Flow | -2.08T | -650.59B | -372.06B | 107.53B | 1.89T | -89.64B |
| Operating Cash Flow | -718.21B | 203.58B | 250.55B | 741.29B | 2.73T | 557.25B |
| Investing Cash Flow | -5.16T | -1.63T | -841.46B | 547.58B | -3.02T | -1.47T |
| Financing Cash Flow | 4.69T | -1.12T | -606.22B | 191.52B | 602.22B | 2.19T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $110.89B | 5.74 | 21.92% | 4.42% | 0.20% | 61.54% | |
76 Outperform | $238.12B | 22.34 | 18.18% | 1.75% | 7.30% | 17.67% | |
72 Outperform | $210.80B | 12.35 | 16.86% | 6.60% | 2.42% | 102.17% | |
67 Neutral | $196.09B | 9.18 | 20.43% | 4.56% | 1.98% | 150.68% | |
62 Neutral | $79.29B | 18.23 | 22.81% | 2.69% | 1.14% | 83.48% | |
61 Neutral | $146.85B | 7.41 | 15.53% | 0.22% | 8.09% | 45.49% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |